Thalamic gliomas—mainly bilateral at the onset, showing EGFR variants, EZHIP (ex CXorf67) overexpression, and loss of H3.3K27me3 in the absence of H3F3A variants—have recently been described. Here, EZHIP is linked to central nervous system cancer.